Clinical trial
Evaluation of a Combined MR Sequence for Simultaneous T2- and T1-Weighted Brain Imaging in Multiple Sclerosis
NCT07687693 is registered in ClinicalTrials.gov with Region Stockholm as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of a Combined MR Sequence for Simultaneous T2- and T1-Weighted Brain Imaging in Multiple Sclerosis
- Lead sponsor
- Region Stockholm
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 10, 2026
- Completion date
- August 31, 2026
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.